Meningococcal vaccines formulated with interleukin-12
US6841160B2 · kind B2 · utility
3Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2003 |
| Grant date | Jan 11, 2005 |
| Priority date | — |
| Expiry date | Jan 23, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6037
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to vaccine compositions comprising a mixture of antigen, such as pneumococcal or meningococcal antigen, and interleukin IL-12, which may be adsorbed onto a mineral in suspension. The pneumococcal or meningococcal antigen may be conjugated to a carrier molecule. These vaccine compositions modulate the protective immune response to the antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.